[{"AccountsPayableCurrent_0_Q2_USD":3414000.0,"LeaseCost_1_Q2_USD":1556000.0,"IncreaseDecreaseInOtherNoncurrentAssets_2_Q2_USD":-43000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_0_Q2_item":10.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss_0_Q2_USD":2000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months_0_Q2_USD":19551000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions_0_Q2_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":3215000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":13948000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":92497000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":67981000.0,"AdvancesOnInventoryPurchases_0_Q2_USD":3000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1778000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-1526000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":207000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":5000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":7293000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":3781000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1757000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-23477000.0,"ShortTermInvestments_0_Q2_USD":56028000.0,"InvestmentsFairValueDisclosure_0_Q2_USD":68027000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":6000.0,"ProceedsFromLongTermLinesOfCredit_2_Q2_USD":9975000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q2_USD":-17576000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_2_Q2_USD":3667000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":1111000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":6667000.0,"LeaseCost_2_Q2_USD":3147000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":6667000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":26307000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":10485000.0,"ValuationAllowancesAndReservesDeductions_2_Q2_USD":4266000.0,"ValuationAllowancesAndReservesChargedToCostAndExpense_2_Q2_USD":5256000.0,"ValuationAllowancesAndReservesBalance_0_Q2_USD":4322000.0,"SubleaseIncome_2_Q2_USD":2687000.0,"SubleaseIncome_1_Q2_USD":1369000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":16021000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":71782000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":30363000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":14214000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_2_Q2_USD":62770000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":1877000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":42980000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings_2_Q2_USD":0.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":23000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-32000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":21911000.0,"OperatingLeasePayments_2_Q2_USD":4832000.0,"OperatingLeasePayments_1_Q2_USD":2432000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":15249000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":8054000.0,"OperatingLeaseLiability_0_Q2_USD":23303000.0,"OperatingLeaseCost_2_Q2_USD":2680000.0,"OperatingLeaseCost_1_Q2_USD":1340000.0,"LongTermLoansPayable_0_Q2_USD":19816000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":3004000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":4863000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":10082000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":877000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_0_Q2_USD":5555000.0,"InvestmentIncomeInterest_2_Q2_USD":527000.0,"InvestmentIncomeInterest_1_Q2_USD":169000.0,"StockholdersEquity_0_Q2_USD":63210000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-1272561000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":2381000.0,"ProfitLoss_2_Q2_USD":3667000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":7182000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":563000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-17131000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":19227000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":11852000.0,"LiabilitiesCurrent_0_Q2_USD":34760000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":138035000.0,"InventoryNet_0_Q2_USD":1684000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-2280000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":1616000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-738000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":0.02,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.1,"CostsAndExpenses_2_Q2_USD":68147000.0,"CostsAndExpenses_1_Q2_USD":33413000.0,"CommonStockValue_0_Q2_USD":169000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":36469000.0,"AssetsCurrent_0_Q2_USD":113090000.0,"Assets_0_Q2_USD":138035000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":26536000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":27942000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":46000.0,"AccountsReceivableNetCurrent_0_Q2_USD":11727000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":168519000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":168570000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"IncreaseDecreaseInOtherAccruedLiabilities_2_Q2_USD":818000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":335000.0,"OperatingLeaseExpense_2_Q2_USD":3798000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":3690000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-17608000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1335556000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":7637000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":168519000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":168570000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q2_USD":541000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_0_Q2_shares":11013055.0,"OtherAssetsNoncurrent_0_Q2_USD":653000.0,"LongTermDebt_0_Q2_USD":20000000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":434000.0,"VariableLeaseCost_1_Q2_USD":216000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":279000.0,"InventoryFinishedGoods_0_Q2_USD":1171000.0,"IncreaseDecreaseInInventories_2_Q2_USD":277000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":168570000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":168525000.0,"ShareBasedCompensation_2_Q2_USD":3781000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":37350000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":18920000.0,"PreferredStockValue_0_Q2_USD":null,"OperatingIncomeLoss_2_Q2_USD":3635000.0,"OperatingIncomeLoss_1_Q2_USD":-17392000.0,"InterestPaidNet_2_Q2_USD":448000.0,"InterestExpense_2_Q2_USD":495000.0,"InterestExpense_1_Q2_USD":353000.0,"InventoryWorkInProcess_0_Q2_USD":513000.0,"VariableLeaseCost_2_Q2_USD":467000.0,"Ticker":"RIGL","CIK":"1034842","name":"RIGEL PHARMACEUTICALS INC","OfficialName":"Rigel Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"488447519.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200804"}]